Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies.
View / Open Files
Authors
Khalil, Bilal
Cabirol-Pol, Marie-Jeanne
Miguel, Laetitia
Whitworth, Alexander J
Lecourtois, Magalie
Liévens, Jean-Charles
Publication Date
2017-06Journal Title
Neurobiology of Aging
ISSN
0197-4580
Publisher
Elsevier BV
Volume
54
Pages
71-83
Language
eng
Type
Article
This Version
AM
Metadata
Show full item recordCitation
Khalil, B., Cabirol-Pol, M., Miguel, L., Whitworth, A. J., Lecourtois, M., & Liévens, J. (2017). Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies.. Neurobiology of Aging, 54 71-83. https://doi.org/10.1016/j.neurobiolaging.2017.02.016
Abstract
Transactive response DNA-binding protein 43 kDa (TDP-43) is considered a major pathological protein in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. The precise mechanisms by which TDP-43 dysregulation leads to toxicity in neurons are not fully understood. Using TDP-43-expressing Drosophila, we examined whether mitochondrial dysfunction is a central determinant in TDP-43 pathogenesis. Expression of human wild-type TDP-43 in Drosophila neurons results in abnormally small mitochondria. The mitochondrial fragmentation is correlated with a specific decrease in the mRNA and protein levels of the Drosophila profusion gene mitofusin/marf. Importantly, overexpression of Marf ameliorates defects in spontaneous walking activity and startle-induced climbing response of TDP-43-expressing flies. Partial inactivation of the mitochondrial profission factor, dynamin-related protein 1, also mitigates TDP-43-induced locomotor deficits. Expression of TDP-43 impairs neuromuscular junction transmission upon repetitive stimulation of the giant fiber circuit that controls flight muscles, which is also ameliorated by Marf overexpression. We show here for the first time that enhancing the profusion gene mitofusin/marf is beneficial in an in vivo model of TDP-43 proteinopathies, serving as a potential therapeutic target.
Keywords
ALS, Dynamin-related protein 1, FTLD, Mitochondria, Mitochondrial dynamics, Animals, DNA-Binding Proteins, Disease Models, Animal, Drosophila, Drosophila Proteins, Dynamins, Gene Expression, Locomotion, Membrane Proteins, Mitochondria, Mitochondrial Dynamics, Molecular Targeted Therapy, Neuromuscular Junction, Neurons, RNA, Messenger, TDP-43 Proteinopathies
Sponsorship
B. K. had a PhD fellowship from the Ministère de la Recherche. J. C. L. and M. L. are supported by a grant from the Association pour la recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone (ARSLA). M. L. is also supported by a grant from the Région Haute-Normandie.
Funder references
Medical Research Council (MC_UP_1501/1)
Medical Research Council (MC_UU_00015/6)
Identifiers
External DOI: https://doi.org/10.1016/j.neurobiolaging.2017.02.016
This record's URL: https://www.repository.cam.ac.uk/handle/1810/291288
Rights
All rights reserved
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.